MiniMed to Participate in Upcoming Investor Conferences
MiniMed (Nasdaq: MMED) will participate in three investor conferences, with Chief Financial Officer Chad Spooner discussing the company and answering questions.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
MiniMed (Nasdaq: MMED) will participate in three investor conferences, with Chief Financial Officer Chad Spooner discussing the company and answering questions. Appearances are scheduled for the Evercore Healthcare Conference on December 1, 2026, Citi's Global Healthcare Conference on December 2, and Piper Sandler's Healthcare Conference on December 3. Live webcasts and replays will be available on MiniMed's investor relations website.
AI-generated analysis. How Rhea-AI works. Not financial advice.
9th Annual Evercore Healthcare Conference
Tuesday, December 1, 2026, at 10:50 a.m. EST / 7:50 a.m. PST
Citi's 2026 Global Healthcare Conference
Wednesday, December 2, 2026, at 11:00 a.m. EST / 8:00 a.m. PST
Piper Sandler 38th Annual Healthcare Conference
Thursday, December 3, 2026, at 11:30 a.m. EST / 8:30 a.m. PST
Live webcasts and replays will be accessible on the MiniMed Investor Relations website: investors.minimed.com/events.
About MiniMed
MiniMed is a global leader in insulin delivery, constantly advancing therapies that support people with diabetes in more than 80 countries. Our full-stack, integrated ecosystem, including our insulin delivery systems, CGMs, algorithms, and easy-to-use app experience, is designed to work seamlessly together, supported by white-glove, wrap-around service. For over 40 years, we've pioneered therapies people can rely on by anticipating needs, reducing burden, and helping make life with diabetes easier. Our mission is to make every day a better day for people with diabetes.
Any forward-looking statements are subject to risks and uncertainties such as those described in MiniMed's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
View original content to download multimedia:https://www.prnewswire.com/news-releases/minimed-to-participate-in-upcoming-investor-conferences-302930023.html
SOURCE MiniMed